Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Finasteride reduces prostate cancer risk but may increase high-grade cancer risk.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Finasteride reduces prostate cancer risk but may increase high-grade cancer cases.

Finasteride lowers prostate cancer risk but may increase high-grade tumors and sexual side effects.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

Hair loss in middle-aged women is often linked to insulin resistance and a family history of hair loss, particularly from their fathers.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Early hair loss links to metabolic issues in young Indian men.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

New guidelines and referral pathways for skin conditions aim to improve care and referrals in Pakistan.

Androgenetic alopecia may predict metabolic syndrome, so routine screening is recommended to prevent cardiovascular issues.

The study concluded that female pattern hair loss is linked to psychological distress and is hard to diagnose and treat, with its causes still not fully understood.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

Taking biotin supplements can cause incorrect thyroid test results, leading to wrong diagnoses.

A new AI model diagnoses hair and scalp disorders with 92% accuracy, better than previous models.

HairLossMultinet accurately classifies hair damage with 98% accuracy but needs a more diverse dataset for broader use.

Over half of postmenopausal women experience hair loss, with severity increasing with age, time since menopause, and higher body mass index.

The F4 polyherbal sunscreen is a promising natural alternative with effective UV protection and antioxidant benefits.

Finasteride is effective for hair loss and may help prevent prostate cancer without increasing high-grade cancer risk.

Finasteride can't be recommended for cancer prevention due to concerns about high-grade cancer risk.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Mesothelioma of the tunica vaginalis testis is rare, often high-grade, and has a median survival of about 24 months.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

High chromogranin A levels are linked to obesity and inflammation in polycystic ovary syndrome.